Uncategorised - European Medical Journal

Conceptual illustration of intranasal H5N1 vaccine activating mucosal and systemic immune responses

Intranasal Vaccine Boosts Protection Against Bird Flu

An intranasal bird flu vaccine safely primes broad mucosal and systemic immunity in a Phase I trial.

eczema

Eczema Trial Finds No Difference Between Daily and Weekly Washing

A UK online trial found that daily and weekly bathing make no difference to eczema symptoms.

Conservative Dialysis Strategy Improves Kidney Recovery in Acute Kidney Injury

A major clinical trial shows that a conservative, indication-based dialysis strategy improves kidney recovery and reduces complications in acute kidney injury.

Regional Differences in LAMA Use for Severe Asthma Across Europe

A European survey of 470 clinicians shows major differences in how LAMAs are prescribed for severe asthma.

Study Finds No Link Between Diet, Urinary pH, and UTIs

New research shows no clear link between diet, urinary pH, and recurrent UTIs in postmenopausal women. Learn more about this pilot study’s findings.

Penicillin vial and syringe on blue background illustrating antibiotic allergy assessment and delabeling

Are Antibiotic Allergy Labels Costing Patients Options?

Antibiotic allergy delabeling is a core stewardship strategy that reduces resistance and improves patient outcomes nationwide.

young adult rheumatology transitional care priorities concept

What Do Young Adults Need in Rheumatology Care?

Young adult rheumatology transitional care benefits when patient priorities directly guide targeted service improvements and design.

Genomic Profiling Guides Targeted Treatment in Advanced Prostate Cancer

Genomic profiling revealed druggable targets in 39% of advanced prostate cancer cases, guiding personalised treatments.

Close-up of a person examining mild acne and blemishes on their cheek, illustrating skin recurrence and dermatologic care.

Key Lifestyle Factors Behind Acne Recurrence

Acne recurrence may be predicted with high accuracy using a new early warning model that incorporates both lifestyle and psychological risk factors.

5 minutes with Benedikt von Thüngen, CEO, Sanome

Benedikt von Thüngen, Founder and CEO, Sanome, shares the origin story of his business, its biggest challenge to date and what pharma needs to know about AI.